Sulfavant A

Sulfavant A

289898-50-6

Colorless waxy substance

sodium ((2S,4R,5R,6R)-6-(2,3-bis(stearoyloxy)propoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methanesulf onate；1,2-O-distearoyl-3-O-β-D-sulfoquinovosylglycerol；β-SQDG18

Sulfavant A (AK0148) has achieved experimental scale supply to well-known domestic and foreign enterprises, and its product quality has received unanimous praise, surpassing similar products in the market, providing good support for the stable quality of downstream products.Sulfavant A (AK0148) customizes products for our company and welcomes new and old customers to inquire.

Application:

Sulfovant A  is the first synthetic small molecule to selectively target TREM2, which can be used in studies related to TREM-2 dysfunction, such as Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), stroke, Alzheimer's disease (AD), and traumatic brain injury, and can also be used as a vaccine adjuvant.